Cell Growth & Differentiation, Vol 9, Issue 8 619-627, Copyright © 1998 by American Association of Cancer Research

ARTICLES

Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines

DL Crowe and CF Shuler
Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles 90033, USA.

The chemotherapeutic agent and vitamin A metabolite retinoic acid (RA) has been used to treat many tumor types. The effects of RA are mediated by a family of ligand-dependent transcription factors, the RA receptors and the retinoid X receptors (RXR). Alterations in retinoid receptor expression have been implicated in tumorigenesis. Previous studies have shown lack of RXR-gamma expression in squamous cell carcinoma (SCC) lines. To begin to elucidate the role of RXR-gamma in the malignant transformation of SCCs, we expressed RXR-gamma in SCC lines by stable transfection. SCC lines expressing RXR-gamma produced large numbers of flat cells with abundant cytoplasm, which died and detached from the culture dish. These cells morphologically resembled the differentiated cells of normal stratified squamous epithelium in culture. These cells did not exhibit the characteristic DNA fragmentation pattern of apoptotic cells, nor did they label in a fluorescent apoptosis assay. RNase protection and Western blot analysis revealed induction of RA-responsive involucrin and keratin 10 expression, early markers of terminal differentiation. RXR-gamma expression produced significant reduction in levels of RA-responsive genes including the cyclin-dependent kinase inhibitors p21Cip1/WAF1 and p27Kip1, resulting in increased cdc2 and cdk2 kinase activity and RB phosphorylation. We concluded that RXR-gamma induced terminal differentiation in SCC lines, suggesting a potential tumor suppressor function for this transcription factor.

This article has been cited by other articles:

				S. Nagpal, S. Na, and R. Rathnachalam Noncalcemic Actions of Vitamin D Receptor Ligands Endocr. Rev., August 1, 2005; 26(5): 662 - 687. [Abstract] [Full Text] [PDF]

				M. Gariboldi, M. Spinola, S. Milani, C. Pignatiello, K. Kadota, H. Bono, Y. Hayashizaki, T. A. Dragani, and Y. Okazaki Gene expression profile of normal lungs predicts genetic predisposition to lung cancer in mice Carcinogenesis, November 1, 2003; 24(11): 1819 - 1826. [Abstract] [Full Text] [PDF]

				D. L. Crowe, R. Kim, and R. A.S. Chandraratna Retinoic Acid Differentially Regulates Cancer Cell Proliferation via Dose-Dependent Modulation of the Mitogen-Activated Protein Kinase Pathway Mol. Cancer Res., May 1, 2003; 1(7): 532 - 540. [Abstract] [Full Text] [PDF]

				E. Nabeyrat, S. Corroyer, V. Besnard, V. Cazals-Laville, J. Bourbon, and A. Clement Retinoic Acid Protects against Hyperoxia-Mediated Cell-Cycle Arrest of Lung Alveolar Epithelial Cells by Preserving Late G1 Cyclin Activities , October 1, 2001; 25(4): 507 - 514. [Abstract] [Full Text] [PDF]

				E. Nabeyrat, S. Corroyer, R. Epaud, V. Besnard, V. Cazals, and A. Clement Retinoic acid-induced proliferation of lung alveolar epithelial cells is linked to p21CIP1 downregulation Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L42 - L50. [Abstract] [Full Text] [PDF]

				P. A. Hershberger, R. A. Modzelewski, Z. R. Shurin, R. M. Rueger, D. L. Trump, and C. S. Johnson 1,25-Dihydroxycholecalciferol (1,25-D3) Inhibits the Growth of Squamous Cell Carcinoma and Down-Modulates p21Waf1/Cip1 in Vitro and in Vivo Cancer Res., June 1, 1999; 59(11): 2644 - 2649. [Abstract] [Full Text] [PDF]